Allogeneic reactivity–mediated endothelial cell complications after HSCT: a plea for consensual definitions
…, D Michonneau, F Sicre de Fontbrune… - Blood …, 2019 - ashpublications.org
Endothelial cell (EC) activation has been suspected of triggering a group of rare and dismal
complications that can occur after allogeneic hematopoietic stem cell transplantation (HSCT)…
complications that can occur after allogeneic hematopoietic stem cell transplantation (HSCT)…
Management of suspected monogenic lung fibrosis in a specialised centre
…, C Kannengiesser, FS de Fontbrune… - European …, 2017 - Eur Respiratory Soc
At least 10% of patients with interstitial lung disease present monogenic lung fibrosis
suspected on familial aggregation of pulmonary fibrosis, specific syndromes or early age of …
suspected on familial aggregation of pulmonary fibrosis, specific syndromes or early age of …
[HTML][HTML] Eltrombopag added to immunosuppression in severe aplastic anemia
…, J Cavenagh, F Sicre de Fontbrune… - … England Journal of …, 2022 - Mass Medical Soc
Background A single-group, phase 1–2 study indicated that eltrombopag improved the
efficacy of standard immunosuppressive therapy that entailed horse antithymocyte globulin (ATG) …
efficacy of standard immunosuppressive therapy that entailed horse antithymocyte globulin (ATG) …
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
…, M Ecsedi, K Sockel, F Ayuk, S Ajib, FS de Fontbrune… - Leukemia, 2015 - nature.com
Despite major improvements in allogeneic hematopoietic cell transplantation over the past
decades, corticosteroid-refractory (SR) acute (a) and chronic (c) graft-versus-host disease (…
decades, corticosteroid-refractory (SR) acute (a) and chronic (c) graft-versus-host disease (…
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
JW Lee, F Sicre de Fontbrune… - Blood, The Journal …, 2019 - ashpublications.org
Ravulizumab (ALXN1210), a new complement C5 inhibitor, provides immediate, complete,
and sustained C5 inhibition. This phase 3, open-label study assessed the noninferiority of …
and sustained C5 inhibition. This phase 3, open-label study assessed the noninferiority of …
A landscape of germ line mutations in a cohort of inherited bone marrow failure patients
…, JH Dalle, F Sicre de Fontbrune… - Blood, The Journal …, 2018 - ashpublications.org
Bone marrow (BM) failure (BMF) in children and young adults is often suspected to be
inherited, but in many cases diagnosis remains uncertain. We studied a cohort of 179 patients (…
inherited, but in many cases diagnosis remains uncertain. We studied a cohort of 179 patients (…
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf …
…, FB Duarte, M Sebert, FS de Fontbrune… - The Lancet …, 2023 - thelancet.com
The recent application of whole exome or whole genome sequencing unveiled a plethora of
germline variants predisposing to myeloid disorders, particularly myelodysplastic neoplasms…
germline variants predisposing to myeloid disorders, particularly myelodysplastic neoplasms…
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
…, R Ordemann, LP Müller, F Sicre-de-Fontbrune… - Nature medicine, 2018 - nature.com
Individuals with acute myeloid leukemia (AML) harboring an internal tandem duplication (ITD)
in the gene encoding Fms-related tyrosine kinase 3 (FLT3) who relapse after allogeneic …
in the gene encoding Fms-related tyrosine kinase 3 (FLT3) who relapse after allogeneic …
CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
…, V Dessirier, F Sicre de Fontbrune… - Blood, The Journal …, 2015 - ashpublications.org
Interleukin 10 (IL-10)–producing B cells (regulatory B cells [Bregs]) regulate autoimmunity in
mice and humans, and a regulatory role of IL-10–producing plasma cells has been …
mice and humans, and a regulatory role of IL-10–producing plasma cells has been …
Germline DDX41 mutations define a significant entity within adult MDS/AML patients
…, E Raffoux, F Sicre de Fontbrune… - Blood, The Journal …, 2019 - ashpublications.org
Germline DDX41 mutations are involved in familial myelodysplastic syndromes (MDSs) and
acute myeloid leukemias (AMLs). We analyzed the prevalence and characteristics of DDX41…
acute myeloid leukemias (AMLs). We analyzed the prevalence and characteristics of DDX41…